R.J. Reynolds Tobacco Company

R.J. Reynolds Tobacco Company is the second-largest tobacco company in the United States and a primary subsidiary of Reynolds American, which is owned by British American Tobacco. Headquartered in Winston-Salem, North Carolina, the company is historically known for iconic cigarette brands such as Camel, Newport, and Pall Mall. In recent years, the company has pivoted toward a Transforming Tobacco strategy, focusing on the development and commercialization of reduced-risk nicotine products, including vapor and modern oral categories. A significant healthcare-related aspect of the company is its affiliate, Kentucky BioProcessing (KBP), which leverages tobacco plant-based technology for the rapid production of complex proteins and vaccines. KBP gained international attention for its role in manufacturing ZMapp, an experimental treatment for Ebola, and for developing plant-based vaccine candidates for COVID-19. This intersection of agricultural technology and biotechnology positions the company as a unique player in the biomanufacturing space, despite its primary identity as a tobacco manufacturer.